---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-249270"
form_type: "8-K"
ticker: "PSTV"
cik: "0001095981"
company_name: "PLUS THERAPEUTICS, INC."
filed_at: "2024-11-01T23:59:59+00:00"
generated_at: "2026-05-30T06:48:55.028736+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Plus Therapeutics receives Nasdaq extension until March 4, 2025 to regain minimum equity compliance

## Summary
- Nasdaq Hearings Panel granted extension to March 4, 2025 for Plus Therapeutics to meet $2.5M stockholders' equity minimum.
- Company has been non-compliant since March 8, 2024; hearing was held on October 22, 2024.
- No assurance of regaining compliance; delisting risk remains if equity condition not met by deadline.
- Stock continues trading on Nasdaq Capital Market under ticker PSTV during extension period.

## SEC filing metadata
- accession: 0001193125-24-249270
- form_type: 8-K
- ticker: PSTV
- cik: 0001095981
- company_name: PLUS THERAPEUTICS, INC.
- filed_at: 2024-11-01T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1095981/000119312524249270/0001193125-24-249270-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1095981/000119312524249270/d860547d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-249270
- JSON: https://secwatch.observer/filing/0001193125-24-249270.json
- Plain text: https://secwatch.observer/filing/0001193125-24-249270.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.